Drug discovery method

作者: Robert B. Perni , John A. Thomson , Cynthia Gates

DOI:

关键词:

摘要: The application discloses a method for selecting Hepatitis C (HCV) inhibitors that form long-lived, tight complexes (EI complex) with their targets (eg NS3/4a protease). It also the compound VX-950 which has such properties and its medical use treating HCV infection eliminating contamination. of cellular viral replication assays are equally claimed.

参考文章(42)
Philip Stephen Jones, David Nigel Hurst, Tony Michael Raynham, Paul Brittain Kay, Michael Richard Attwood, Francis Xavier Wilson, Peptidyl inhibitors of viral proteases ,(1997)
Robert B. Perni, Luc J. Farmer, John van Drie, Lawrence F. Courtney, Janos Pitlik, Bridged bicyclic serine protease inhibitors ,(2002)
Stefania Colarusso, Jesus Maria Ontoria Ontoria, Alessia Petrocchi, Frank Narjes, Vincenzo Summa, Cristina Gardelli, Simona Ponzi, Benjamin Gerlach, Steven Harper, Uwe Koch, Ian Stansfield, Victor Giulio Matassa, Ester Muraglia, Peptides and their use as inhibitors of hepatitis C virus ns3 protease ,(2002)
E. Scott Priestley, Carl P. Decicco, Lactam inhibitors of hepatitis c virus ns3 protease ,(2000)
Ursula A. Germann, Ted Fox, Keith Philip Wilson, Michael Shin-San Su, Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases ,(1999)